How risk influences the choice of governance mode in biopharmaceutical inter-firm relationships

International Business Review

Volumn 22, Issue 6, 2013, Pages 932-950

  Billitteri, Carolina ^a   Nigro, Giovanna Lo ^a   Perrone, Giovanni ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Biopharmaceutical industry; Governance structure; Inter firm relationship; Performance risk; Relational risk

Indexed keywords

EID: 84881666521     PISSN: 09695931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ibusrev.2013.01.011     Document Type: Article

References (108)

1. Adner R., Levinthal D.A. What is not a real option: Identifying boundaries for the application of real options to business strategy. Academy of Management Review 2004, 29(1):74-85.
2. Aghion P., Tirole J. The management of innovation. The Quarterly Journal of Economics 1994, 109(4):1185-1209.
3. Ahuja G., Lampert C.M. Entrepreneurship in the large corporation: A longitudinal study of how established firms create breakthrough ideas. Strategic Management Journal 2001, 22:521-543.
4. Alchian A.-A., Demsetz H. The property right paradigm. Journal of Economic History 1973, 33:16-27.
5. Anand B.H., Khanna T. Do firms learn to create value? The case of alliances. Strategic Management Journal 2000, 21:295-315.
6. Arinõ A., Ragozzino R., Reuer J.J. Alliance dynamics for entrepreneurial firms. Journal of Management Studies 2008, 45(1):147-168.
7. Barkema H.G., Vermeulen F. What differences in the cultural backgrounds of partners are detrimental for international joint ventures?. Journal of International Business Studies 1997, 28(4):845-864.
8. Billitteri C., Lo Nigro G., Perrone G. Drivers influencing the governance of inter-firm relationships in the biopharmaceutical industry: An empirical survey in the Italian context. Technology Analysis & Strategic Management 2013, 25(1):107-126.
9. Bleeke J., Ernst D. Is your strategic alliance really a sale?. Harvard Business Review 1995, 73(1):97-105.
10. Bosse D.-A., Alvarez S.-A. Bargaining power in alliance governance negotiations: Evidence from the biotechnology industry. Technovation 2010, 30:367-375.
11. Bradfield R., El-Sayed H. Four scenarios for the future of the pharmaceutical industry. Technology Analysis & Strategic Management 2009, 21(2):195-212.
12. Brouthers K.D. The influence of international risk on entry mode strategy in the computer software industry. Management International Review 1995, 35(1):7-28.
13. Chiesa V., Toletti G. Network of collaborations for innovation: The case of biotechnology. Technology Analysis & Strategic Management 2004, 16(1):73-96.
14. CHPR. (2011). Napo Pharmaceuticals Inc files suit against Salix Pharmaceuticals Ltd for breach of contract pertaining to lead drug candidate. Factiva, p. 4.
15. Cohen W., Levinthal D. Absorptive capacity: A new perspective on learning and innovation. Administrative Science Quarterly 1990, 35(1):128-152.
16. Danzon P.M., Epstein A., Nicholson S. Mergers and acquisitions in the pharmaceutical and biotech industries. Managerial and Decision Economics 2007, 28:307-328.
17. Das T.K., Teng B.S. Risk types and inter-firm alliance structure. Journal of Management Studies 1996, 33:827-843.
18. Das T.K., Teng B.S. Between trust and control: Developing confidence in partner cooperation in alliances. The Academy of Management Review 1998, 23(3):491-512.
19. Das T.K., Teng B.S. A resource-based theory of strategic alliances. Journal of Management 2000, 26(1):31-61.
20. Das T.K., Teng B.S. A risk perception model of alliance structuring. Journal of International Management 2001, 7:1-29.
21. David R.J., Han S. A systematic assessment of the empirical support for transaction cost economics. Strategic Management Journal 2004, 25(1):39-58.
22. Delerue H. Relational risk perception in European biotechnology alliances. European Management Journal 2004, 22(5):546-556.
23. Delerue H., Simon E. National cultural values and the perceived relational risks in biotechnology alliance relationships. International Business Review 2009, 18:14-25.
24. de Man A.P., Roijakkers N. Alliance governance: Balancing control and trust. Long Range Planning 2009, 42:75-95.
25. DiMasi J.A. Risk in new drug development: Approval success rates for investigational drugs. Clinical Pharmacology and Therapeutics 2001, 69:297-307.
26. DiMasi J., Grabowski H.G. The cost of biopharmaceutical R&D: Is biotech different?. Managerial and Decision Economics 2007, 28:469-479.
27. DiMasi J.A., Hansen R.W., Grabowski H.G. The price of innovation: New estimates of drug development cost. Journal of Health Economics 2003, 22:151-185.
28. Dyer J.H., Singh H. The relational view: Cooperative strategy and sources of interorganizational competitive advantage. Academy of Management Review 1998, 23(4):660-679.
29. Dunne D.D., Gopalakrishnan S., Scillitoe J.L. An empirical study of the impact of firm resources on alliance governance structures. Journal of Engineering and Technology Management 2009, 26:181-195.
30. Folta T. Governance and uncertainty: The trade-off between administrative control and commitment. Strategic Management Journal 1998, 19(11):1007-1028.
31. Folta T., Leiblein M. Technology acquisition and the choice of governance by established firms: Insights from option theory in a multinomial logit model. Academy of Management Proceedings 1994, 27-31.
32. Goozner M. The ®800 million pill: The truth behind the cost of new drugs 2004, University of California Press, Berkeley, CA.
33. Gopalakrishnan S., Scillitoe J.L., Santoro M.D. Tapping deep pockets: The role of resources and social capital on financial capital acquisition by biotechnology firms in biotech-pharma alliances. Journal of Management Studies 2008, 45(8):1354-1376.
34. Grossman S.-J., Hart O.-D. The costs and benefits of ownership: A theory of vertical and lateral integration. Journal of Political Economy 1986, 94(4):691-719.
35. Gulati R. Does familiarity breed trust? The implications of repeated choice for contractual ties in alliances. Academy of Management Journal 1995, 38(1):85-112.
36. Gulati R., Singh H. The architecture of cooperation: Managing coordination costs and appropriation concerns in strategic alliances. Administrative Science Quarterly 1998, 43(4):781-814.
37. Gulati R., Nohria N., Zaheer A. Strategic networks. Strategic Management Journal 2000, 21(3):203-215.
38. Hagedoorn J. Understanding the rational of strategic technology partnering: Introrganizational modes of cooperation and sectorial differences. Strategic Management Journal 1993, 14:371-385.
39. Hagedoorn J., Duysters G. External sources of innovative capabilities: The preference for strategic alliances or mergers and acquisitions. Journal of Management Studies 2002, 39(2):167-188.
40. Hagedoorn J., Sadowski B. The transition from strategic technology alliances to mergers and acquisitions: An exploratory study. Journal of Management Studies 1999, 36(1):87-107.
41. Hagedoorn J., Cloodt D., van Kranenburg H. Intellectual property rights and the governance of international R&D partnerships. Journal of International Business Studies 2005, 36:175-186.
42. Harrigan K.R. Strategies for joint ventures 1985, Lexington Books, Lexington, MA.
43. Harrigan K.R. Strategic alliances and partner asymmetries. Cooperative strategies in international business 1988, Lexington Books, Lexington, MA. F.J. Contractor, P. Lorange (Eds.).
44. Hart O.D., More J. Property rights and the nature of the firm. The Journal of Political Economy 1990, 98(6):1119-1158.
45. Higgins M.J., Rodriguez D. The outsourcing of R&D through acquisitions in the pharmaceutical industry. Journal of Financial Economics 2006, 80(2):351-383.
46. Hitt M.A., Dacin M.T., Levitas E., Arregle J.L., Borza A. Partner selection in merging and developed market contexts: Resource-based and organizational learning perspectives. Academy of Management Journal 2000, 43:449-467.
47. Krishnan, A. (2011). Amylin secures restraining order against Eli Lilly. IHS Global Insight Daily Analysis, p. 205.
48. Janney J.J., Dess G.G. Can real-options analysis improve decision-making? Promises and pitfalls. Academy of Management Executive 2004, 18(4):60-75.
49. Janney J.J., Folta T.B. Signaling through private equity placements and its impact on the valuation of biotechnology firms. Journal of Business Venturing 2003, 18:361-380.
50. Jiang X., Li Y., Gao S. The stability of strategic alliances: Characteristics, factors and stages. Journal of International Management 2008, 14:173-189.
51. Jones E. Onyx claims breach of contract against Bayer. Drug Industry Daily 2009, 8(97):15-17.
52. Judge W.Q., Dooley R. Strategic alliance outcomes: A transaction-cost economics perspective. British Journal of Management 2006, 17:23-37.
53. Kale P., Singh H. Building firms capabilities through learning: The role of the alliance learning process in alliance capability and firm-level alliance success. Strategic Management Journal 2007, 28:981-1000.
54. Kale P., Singh H., Perlmutter H. Learning and protection of proprietary assets in strategic alliances: Building relational capital. Strategic Management Journal 2000, 21(3):217-237. (Special Issue: Strategic Networks).
55. Klein B., Crawford R., Alchian A. Vertical integration: Appropriable rents and the competitive contracting process. Journal of Law and Economics 1978, 21:279-326.
56. Knight F.H. Risk, uncertainty, and profit 1921, Hart, Schaffner & Marx; Houghton Mifflin Company, Boston, MA.
57. Kogut B. Joint ventures and the option to expand and acquire. Management Science 1991, 37:19-33.
58. Kogut B., Singh H. The effect of national culture on the choice of entry mode. Journal of International Business Studies 1988, 19:411-432.
59. Lambe C.J., Spekman R.E. Alliances, external technology acquisition, and discontinuous technology change. Journal of Product Innovation Management 1997, 14(2):102-116.
60. Lane H.W., Beamish P.W. Cross-cultural cooperative behavior in joint ventures in LCDs. Management International Review 1990, 30:87-102.
61. Leiblein M.J. The choice of organizational governance form and performance: Predictions from transaction cost, resource-based, and real options theories. Journal of Management 2003, 29(6):937-961.
62. Leiblein M.J., Miller D.J. An empirical examination of transaction- and firm-level influences on the vertical boundaries of the firm. Strategic Management Journal 2003, 24(9):839-860.
63. Lo Nigro G., Abbate L. Risk assessment and profit sharing in business networks. International Journal of Production Economics 2011, 131:234-241.
64. Lo Nigro G., Perrone G., Chiapparone S. Governance forms drivers in bio-pharmaceutical inter-firm relation. International Journal of Production Economics 2012, 140(2):604-613.
65. Mahoney J.T. The choice of organizational form: Vertical financial ownership versus other methods of vertical integration. Strategic Management Journal 1992, 13(8):559-584.
66. McCutchen W.W., Swamidass P.M. Motivations for strategic alliances in the pharmaceutical/biotech industry: Some new findings. Journal of High Technology Management Research 2004, 15(2):197-214.
67. McCutchen W.W., Swamidass P.M., Teng B.S. Strategic alliance termination and performance: The role of task complexity, nationality and experience. Journal of High Technology Management Research 2008, 18:191-202.
68. Miller K.D. A framework for integrating risk management in international business. Journal of International Business Studies 1992, 23:311-331.
69. Myers S. Determinants of capital borrowing. Journal of Financial Economics 1977, 5:147-175.
70. Newswire P.R. Ligand elects to receive milestone payments from Pfizer in Ligand Common Stock; Ligand could retire over 101,000 shares. Factiva 1996, 32-45.
71. Nooteboom B. Trust, opportunism and governance: A process and control model. Organization Studies 1996, 17(6):985-1010.
72. Nooteboom B., Berger H., Noorderhaven N.G. Effect of trust and governance on relational risk. Academy of Management Journal 1997, 40(2):308-338.
73. Oliver C. Determinants of interorganizational relationships: Integration and future directions. Academy of Management Review 1990, 15:241-265.
74. Oxley J.E. Appropriability hazards and governance in strategic alliances: A transaction cost approach. The Journal of Law, Economics, Organization 1997, 13(2):387-409.
75. Oxley J.E. Institutional environment and the mechanisms of governance: The impact of intellectual property protection on the structure of inter-firm alliances. Journal of Economic Behavior & Organization 1999, 38(3):283-309.
76. Oxley J.E., Sampson R.C. The scope and governance of international R&D alliances. Strategic Management Journal 2004, 25:723-749.
77. Pangarkar N., Klein S. The impacts of alliance purpose and partner similarity on alliance governance. British Journal of Management 2001, 12:341-353.
78. Parkhe A. Interfirm diversity, organizational learning, and longevity in global strategic alliances. Journal of International Business Studies 1991, 22(4):579-601.
79. Parkhe A. Strategic alliance structuring: A game theoretic and transaction cost examination of interfirm cooperation. The Academy of Management Journal 1993, 36(4):794-829.
80. Pisano G.P. The R&D boundaries of the firm: An empirical analysis. Administrative Science Quarterly 1990, 35(1):153-176. (Special Issue: Technology, Organizations, and Innovation).
81. Pisano G.P. Science business 2006, Harvard Business School Press.
82. Powell W.W., Koput K.W., Smith-Doerr L. Interorganizational collaboration and the locus of innovation: Networks of learning in biotechnology. Administrative Science Quarterly 1996, 41:116-145.
83. Rese M., Roemer E. Managing commitments and flexibility by real options. Industrial Marketing Management 2004, 33(6):501-512.
84. Reuer J.J., Leiblein M.J. Downside risk implications of multinationality and international joint ventures. Academy of Management Journal 2000, 43:203-214.
85. Ring P.S., Van de Ven A.H. Structuring cooperative relationship between organization. Strategic Management Journal 1992, 13:483-498.
86. Ring P.S., Van de Ven A.H. Developmental processes of cooperative inter-organizational relationships. Academy of Management Review 1994, 19(1):90-118.
87. Roemer, E. (2004). Real option and the theory of the firm. Bradford University School of Management. Working paper series.
88. Rosiello A. At the interfaces of governance and competence perspectives: Discussing organizational choices in the Scottish biotechnology cluster. Technology Analysis & Strategic Management 2007, 19(1):45-68.
89. Rothaermel F.T. Complementary assets, strategic alliances, and the incumbent's advantage: An empirical study of industry and firm effects in the biopharmaceutical industry. Research Policy 2001, 30(8):1235-1251.
90. Rothaermel F.T., Deeds D.L. Alliance type, alliance experience, and alliance management capability in high-technology ventures. Journal of Business Venturing 2006, 21(4):429-460.
91. Sampson R.C. Organizational choice in R&D alliances: Knowledge-based and transaction cost perspectives. Managerial and Decision Economics 2004, 25:421-436.
92. Santoro M.D., McGill J.P. The effect of uncertainty and asset co-specialization on governance in biotechnology alliances. Strategic Management Journal 2005, 26(13):1261-1269.
93. Sitkin S.B., Pablo A.L. Reconceptualizing the determinants of risk behavior. Academy of Management Review 1992, 17(1):9-38.
94. Steensma H.K., Fairbank J.F. Internalizing external technology: A model of governance mode choice and an empirical assessment. The Journal of High Technology Management Research 1999, 10(1):1-35.
95. Teng B.S., Das T.K. Governance structure choice in strategic alliances. The roles of alliance objectives, alliance management experience, and international partners. Management Decision 2008, 46(5):725-742.
96. Trajtenberg, M., Jaffe, A. B., Hall, B. H. (2001). The NBER patent citation data file: Lessons, insight and methodological tools. NBER Working Paper N. 8498.
97. Tushman M.L., Anderson P.C. Technological discontinuities and organizational environments. Administrative Science Quarterly 1986, 31:439-465.
98. Van de Vrande V., Vanhaverbeke W., Duysters G. External technology sourcing: The effect of uncertainty of governance mode choice. Journal of Business Venturing 2009, 24:62-80.
99. Vanhaverbeke W., Duysters G., Noorderhaven N. External technology sourcing through alliances or acquisitions: An analysis of the application-specific integrated circuits industry. Organization Science 2002, 13(6):714-733.
100. Villalonga B., McGahan A.-M. The choice among acquisitions, alliances and divestitures. Strategic Management Journal 2005, 26:1183-1208.
101. Wang L., Zajac E. Alliance or acquisition? A dyadic perspective on inter-firm resource combination. Strategic Management Journal 2007, 28:1291-1317.
102. Williamson O.E. The vertical integration of production: Market failure considerations. American Economic Review 1971, 61:112-123.
103. Williamson O.E. Markets and hierarchies: Analysis and antitrust implications 1975, Free Press, New York, NY.
104. Williamson O.E. Transaction cost economics: The governance of contractual relations. Journal of Law and Economics 1979, 22:233-261.
105. Williamson O.E. The economic institutions of capitalism 1985, Free Press, New York, NY.
106. Williamson O.E. Comparative economic organization: The analysis of discrete structural alternatives. Administrative Science Quarterly 1991, 36:269-296.
107. Williamson O.E. Calculativeness, trust, and economic organization. Journal of Law and Economics 1993, 36(1):453-486.
108. Williamson O.E. The new institutional economics: Taking stock, looking ahead. Journal of Economic Literature 2000, 38(3):595-613.